In the present study, it was shown that the vasorelaxing effect of the carbonic anhydrase inhibitors acetazolamide, dorzolamide, methyl bromopyruvate, and ethyl bromopyruvate on porcine retinal arterioles in vitro was similar in the presence of perivascular retinal tissue. This is in accordance with clinical studies showing no difference between the vasorelaxing effect of different carbonic anhydrase inhibitors administered intravenously
4 where the effect is exerted on vessels embedded in a normal retinal environment. In addition, the similar effect of different carbonic anhydrase inhibitors on retinal arterioles with preserved perivascular tissue makes it unlikely that the different effects observed on isolated retinal arterioles had any relation to the preconstriction of the arterioles with U46619, or the slight vasorelaxing effect of the dimethylsulfoxide used to dissolve acetazolamide for the experiments.
The vasorelaxing effect of carbonic anhydrase inhibitors was observed in a concentration range at which acetazolamide and dorzolamide in clinical studies have been shown to induce vasorelaxation
2 13 14 and at a concentration comparable to that obtained after infusion of 500 mg acetazolamide—for example, in therapy for acute glaucoma.
15 Similar findings have been found in animal experiments, both in vitro
3 4 and in vivo.
5 6 However, the findings are highly suggestive that the effective concentration of the carbonic anhydrase inhibitor is much higher than that found in experiments of binding kinetics in vitro.
16 It might therefore be conjectured that the observed effect involves mechanisms other than inhibition of carbonic anhydrase or perhaps is related to a reduced sensitivity of the compounds due to a masking of binding sites.
The maximum effect and the potency of the tested carbonic anhydrase inhibitors appears to be similar in both in vivo and in vitro experiments.
3 5 6 Therefore, it is unlikely that blocking of carbonic anhydrase in erythrocytes that are absent in the nonperfused vessels studied in in vitro experiments is involved in the effect. The vasorelaxation observed in vitro or after systemic administration of carbonic anhydrase inhibitors can therefore be assumed to be due to an effect on the vascular smooth muscle cells alone or on these cells in an interplay with other cellular elements in the surrounding tissue. Previous studies suggest that this effect is not via NO from the endothelium,
7 and the results of the present study support the view that the perivascular retinal tissue is involved. First, the resting tone of the isolated vessels was higher than that of vessels with perivascular tissue suggesting that a vasorelaxing factor released from the perivascular tissue had been eliminated.
11 Second, removal of the perivascular tissue had significant effects on the vasorelaxing effect of the studied carbonic anhydrase inhibitors. However, this response depended on the type of the carbonic anhydrase inhibitor. Thus, removal of the perivascular retinal tissue resulted in an insignificant increase in the tone response and the sensitivity of methyl- and ethyl bromopyruvate. Since the effect of these compounds is mainly on the cytosolic isoenzyme I located in the vascular smooth muscle cells
17 or the vascular endothelial cells,
8 it is likely that the removal of the perivascular retina eliminates a factor interfering with these cells. Conversely, the vasorelaxing effect of dorzolamide and especially acetazolamide was significantly reduced in isolated arterioles, as evidenced by both a reduction in the maximum relaxation and an increase in EC
50. It is therefore highly likely that the vasorelaxing effect of these drugs depends on carbonic anhydrases in the perivascular retina. This effect may have involved different isoenzymes such as cytosolic isoenzyme II in pericytes and retinal Müller cells and membrane-bound isoenzyme XIV located in retinal astrocytes and Müller cells.
8 9 10
In several studies extracellular acidosis has been shown to have a tone-relaxing effect on retinal arterioles.
4 12 18 However, other findings indicate that the tone-relaxing effect of carbonic anhydrase inhibitors is independent of the extracellular acidosis.
6 This notion suggests either that the vasodilating effect of extracellular acidosis is related to a simultaneous presence of intracellular alkalosis
4 or that the vasodilation is due to a direct effect of carbonic anhydrase inhibitors on the vascular smooth muscle cells.
Both acetazolamide and dorzolamide are known to inhibit carbonic anhydrase isoenzyme II, and especially dorzolamide has a strong selectivity for this isoenzyme.
1 17 19 Dorzolamide has been synthesized to possess physicochemical properties that allow its uptake into the eye by diffusion after instillation in the conjunctiva. Systemic absorption of dorzolamide after this route of administration is low,
20 and it has been shown that short-term treatment with this drug does not affect the blood flow in the retina and the optic nerve.
21 22 23 However, it has also been shown that after a few days of local treatment with dorzolamide, the blood flow of the optic nerve is increased as a result of absorption to the posterior part of the eye.
24 25 26 The findings of the present study suggest that this effect is mediated by the perivascular retinal tissue. However, the experiments also indicate that the effect of acetazolamide is different from that of dorzolamide which may reflect that the mechanisms of action of these two compounds differ. Acetazolamide has recently been shown to exert a direct effect on vascular smooth muscle cells through an opening of calcium-activated potassium channels, an effect that is conceivably due to intracellular alkalosis.
16 Opening of these channels leads to inactivation of voltage-gated calcium channels and a consequent relaxation of the vascular smooth muscle cells leading to vasorelaxation. However, this is not the case for acetazolamide in porcine retinal arterioles as these show almost no relaxation in response to acetazolamide in the absence of perivascular tissue. Thus, a more detailed knowledge of the molecular mechanism of action of different carbonic anhydrase inhibitors is needed to understand completely the effect of these compounds on retinal vascular tone. This knowledge might be obtained by including studies of intracellular pH in individual cells of the walls of retinal arterioles and the perivascular retinal tissue. It is conceivable that a full understanding of the vasodilating effect of carbonic anhydrase inhibitors on retinal arterioles may contribute further to the understanding of how retinal perfusion is regulated and point to possible modes of intervention to cure disturbances in the retinal blood flow. The present findings show that these efforts should include considerations of the role of the perivascular retinal tissue in the regulation of retinal blood flow.
The authors thank technician Poul Rostgaard for skillful assistance.